Introduction {#s1}
============

Skeletal muscle is a unique tissue that comprises 40% of our total body mass and is essential for breathing, movement, and metabolism. In contrast to the majority of other cell types, a single skeletal muscle fiber, which is formed from the fusion of precursor cells during development, contains hundreds of nuclei ([@bib12]). Muscle is a remarkably plastic tissue in the adult with the ability to regenerate due to the presence of *bona fide* muscle stem cells (MuSCs or also referred to as satellite cells), and also respond to various stimuli by altering its contractile and metabolic properties ([@bib14]; [@bib19]). Proper regulation of skeletal muscle involves adaptations in the myofiber and an ability for MuSCs to activate and differentiate into muscle progenitors (MPs), which fuse to myofibers thereby increasing myonuclear number. While the role for MP fusion in response to major damage such as cardiotoxin-injury is well-recognized, its function during exercise-induced adaptations continues to be debated.

The adaptive response of skeletal muscle to exercise is diverse and includes an alteration in structure, metabolism, and function. The specific adaptation depends on the exercise stimulus, where resistance training induces an increase of myofiber cross-sectional area (CSA) to deal with increased loads and endurance training elicits greater metabolic changes allowing muscle to become more fatigue resistant. There is consensus that MuSCs are indeed activated in humans after exercise, however whether MuSC activation and downstream myonuclear accretion is required for adaptive hypertrophy is not fully understood ([@bib44]; [@bib37]; [@bib2]). The requirement of myonuclear accretion for hypertrophy may depend on muscle fiber type as growth of 18% in slow, type I myofibers is associated with an increase of myonuclei ([@bib45]; [@bib4]). In contrast, an increase in myonuclear content of fast, type II myofibers is only observed after 26--40% hypertrophy ([@bib45]; [@bib21]; [@bib41]; [@bib46]). Taken together, while muscle adapts to exercise in various ways, the role of MP fusion and associated myonuclear accretion for hypertrophy is not clear.

While informative, the majority of human studies on the response of MuSCs to exercise are correlational in nature and biopsies reflect only a small portion of the entire muscle, therefore model organisms such as the mouse have also been utilized to shed light on MuSC-dependent exercise adaptations. Muscle overload by synergist ablation is the most often used stimulus to drive hypertrophy in the mouse, however it is an invasive procedure where a synergist muscle (e.g., gastrocnemius) is surgically removed leaving a smaller muscle (e.g., plantaris) to do all of the required work to ambulate the limb ([@bib23]). While synergist ablation induces significant hypertrophy, there are questions about its physiological relevance due to its invasive nature and the potential to damage the muscle, and the magnitude of insult is far above anything experienced by muscle undergoing normal exercise. Recent work using models of MuSC ablation through diptheria toxin (DTA) has shown differing results as to whether they are required for hypertrophy in response to synergist ablation ([@bib15]; [@bib16]; [@bib30]; [@bib29]). Current ideas include that MP fusion is required for synergist ablation at young ages (below 4 months of age) but not at older timepoints ([@bib35]). Through a complementary approach, we abrogated MP fusion by genetically deleting Myomaker (*Mymk*), a muscle-specific factor required for fusion, and found that synergist ablation-induced hypertrophy was significantly blunted ([@bib18]). These results are consistent with Egner et al., that the presence of MuSCs are required for growth induced by synergist ablation, but questions still exist about whether there is an age dependence of MP fusion for hypertrophy and if they are required in a physiologically relevant system. While voluntary wheel running is a standard exercise stimulus for the mouse and ablation of MuSCs by DTA have minimal impact on adaptations to voluntary wheel running ([@bib20]; [@bib36]), this exercise stimulus does not lead to significant myofiber hypertrophy ([@bib11]). A progressive weighted wheel running protocol was recently reported to increase myofiber size but it is not understood if this exercise regimen is associated with improved muscle function or if MP fusion is required ([@bib13]). Thus, it is not known if MP fusion is necessary for adaptive hypertrophy in a physiologically-relevant exercise protocol.

In addition to the lack of a physiological hypertrophy-inducing protocol for mice, another challenge in elucidating the role of MP-dependent myonuclear accretion during exercise-induced adaptations is that changes in muscle are dynamic. Indeed, initiation of an exercise regimen leads to mechanical damage of the muscle characterized by alterations of the cytoskeleton and structural proteins ([@bib10]). Because the classical stimulus activating MuSCs is muscle damage it is not surprising they are stimulated in this initial stage of exercise. It has thus been proposed that myonuclear accretion during exercise may occur as an early injury response and not specifically to drive hypertrophy ([@bib37]). Moreover, it is not understood if the increase in myonuclei resulting from accrual during the early response to exercise are sufficient for myofiber growth that occurs at later stages. Overall, a major obstacle in elucidating a causative relationship between MP fusion and myofiber growth has been the lack of a model that uncouples the addition of myonuclei for repair from accretion associated with hypertrophy.

We therefore sought to develop an exercise protocol that leads to muscle hypertrophy, thereby allowing interrogation of the requirement of MP fusion during the process. We utilized a high-intensity interval treadmill protocol (HIIT) that led to progressive myonuclear accretion, consistent hypertrophy of multiple muscles, and improved functional output. Through abrogation of MP fusion by deleting Myomaker in MPs, we demonstrate that myonuclear accrual is essential for normal adaptive remodeling in response to exercise. Most notably, our data indicate that accretion of myonuclei supports temporally distinct adaptive outcomes, which allows us, for the first time, to parse apart myonuclear accrual occurring in response to muscle damage and repair from growth.

Results {#s2}
=======

A high-intensity interval training (HIIT) exercise protocol elicits an increase in muscle weight and strength {#s2-1}
-------------------------------------------------------------------------------------------------------------

A hypertrophy-inducing exercise protocol for mice is lacking ([@bib7]), although recently a high interval training protocol (HIIT) for aged mice was reported ([@bib43]). To determine the role of MP fusogenicity for physiological hypertrophy, we modified this protocol for non-aged adult mice. The aged HIIT protocol lasted 16 weeks and we hypothesized hypertrophy could be maximized in 8 weeks if the amount of work accomplished over 16 weeks could be condensed over 8 weeks. We designed an exercise regimen to increase the amount of work during each week of the protocol by training mice three times per week and either increasing the angle of incline or speed of the treadmill ([Figure 1A](#fig1){ref-type="fig"}). After 1 week of acclimation to the treadmill, 8-month-old wild-type (WT) mice were subjected to a treadmill speed of 15--16 meters/minute with an incline of 10°. Speed remained constant during the initial 4 weeks of the protocol, but incline was increased by 5° each week. For the final 4 weeks, incline was maintained at 25° but speed was progressively increased. Analysis of muscle weights revealed a significant increase of multiple muscle groups in HIIT-trained mice compared to sedentary mice ([Figure 1B](#fig1){ref-type="fig"}). We next performed in vivo functional analysis to assess if HIIT resulted in an increase in muscle strength. The hindlimb plantar flexor muscles were stimulated at multiple frequencies and force was measured throughout each of these contractions, generating a force-frequency curve ([Figure 1C](#fig1){ref-type="fig"}). Peak isometric tetanic force of the hindlimb plantar flexor was increased after HIIT compared to sedentary mice ([Figure 1D](#fig1){ref-type="fig"}). The peak isometric tetanic force curve was then analyzed to calculate the rates by which the muscles contracted and relaxed. We observed an increase in rate of activation ([Figure 1E](#fig1){ref-type="fig"}) but no significant effect on rate of relaxation ([Figure 1F](#fig1){ref-type="fig"}), indicating that HIIT-trained muscle has the capability to generate peak tetanic force more quickly. Finally, calculation of impulse (area under the peak isometric tetanic force curve) revealed an increase after HIIT showing that those muscles can sustain higher force over a single contraction ([Figure 1G](#fig1){ref-type="fig"}). Overall, HIIT leads to an increase in muscle size and strength suggesting that it could represent a novel protocol to investigate exercise-induced adaptations in the mouse.

![High intensity interval training (HIIT) in mice increases muscle size and strength.\
(**A**) Schematic showing the HIIT protocol using a treadmill. During the initial 4 weeks (w) treadmill incline was increased gradually each week while speed remained constant. In the final 4 weeks, incline was set at 25° but speed increased gradually each week. See Materials and methods for further details. (**B**) Muscle weight to tibia length ratios for multiple muscles in sedentary and HIIT-trained (8 weeks) mice. (**C--G**) In vivo isometric tetanic force measurements of plantar flexor muscles demonstrates functional improvements in muscle strength after 8 weeks of HIIT. (**C**) Force-frequency curve, (**D**) peak force, (**E**) rate of force generation, (**F**) rate of contraction relaxation, and (**G**) impulse. Data are presented as mean ± SD. Statistical analyses: (**B**), (**D**), (**E**) unpaired two-tailed Student's t-test, (**G**) Mann-Whitney test. \*p\<0.05, \*\*p\<0.01.](elife-44876-fig1){#fig1}

HIIT induces a progressive increase in myonuclei and hypertrophy {#s2-2}
----------------------------------------------------------------

We next assessed the magnitude and timing of myonuclear accretion at various stages of HIIT. We stained nuclei of isolated myofibers from the extensor digitorum longus (EDL) from sedentary mice and mice subjected to 2, 4, and 8 weeks of HIIT. Qualitatively, we observed an increase of myonuclei at each stage of the protocol ([Figure 2A](#fig2){ref-type="fig"}). Quantification of the number of nuclei per myofiber revealed 227 ± 15 myonuclei from sedentary muscle, whereas myofibers after 2 weeks of HIIT contained 253 ± 11 myonuclei ([Figure 2B](#fig2){ref-type="fig"}). After 4 weeks of HIIT myofibers contained 281 ± 9 and at 8 weeks there were 306 ± 12 myonuclei ([Figure 2B](#fig2){ref-type="fig"}). To complement the analysis of myonuclei in isolated EDL myofibers, we also assessed myonuclear number on cryosections from quadriceps by evaluating the number of nuclei within a dystrophin-stained myofiber. This analysis also revealed an increase in myonuclei ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), consistent with the analysis in EDL myofibers. Moreover, analysis of the relative increase in myonuclei in the quadriceps and EDL showed that the different methods to quantify nuclear number yield similar results ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). These data demonstrate that there is a continuous increase in myonuclei throughout the exercise regimen.

![Persistent myonuclear accretion throughout HIIT while myofiber size increases between 4 and 8 weeks.\
(**A**) Representative single EDL myofibers from sedentary mice or mice subjected to HIIT for various durations. Myofibers were stained with DAPI to identify nuclei. (**B**) Total nuclei number per myofiber was quantified from the myofibers in (**A**) showing that myonuclear accretion occurs throughout the protocol. (**C**) Representative images of muscle sections from sedentary and HIIT-trained mice. Sections were immunostained with laminin antibodies and DAPI. (**D**) Quantification of myofiber cross-sectional area (CSA) in the gastrocnemius and quadriceps from the various groups of mice showing an increase of CSA 8 weeks after initiation of HIIT. Data are presented as mean ± SD. Statistical analyses: (**B**), (**D**) 1-way ANOVA with a Tukey correction for multiple comparisons. \*p\<0.05, \*\*p\<0.01. Scale bars: 100 µm.](elife-44876-fig2){#fig2}

An increase in myofiber size is a normal adaptation to increased workload. We assessed myofiber hypertrophy at multiple time points after HIIT in both the gastrocnemius and quadriceps. Analysis of muscle sections revealed an increase of myofiber size after the entire 8 week HIIT protocol, with minimal gains in size at 2 or 4 weeks post-HIIT ([Figure 2C](#fig2){ref-type="fig"}). Quantification of myofiber cross-sectional area (CSA) indeed showed a significant increase at 8 weeks but not at prior time points ([Figure 2D](#fig2){ref-type="fig"}). Thus, muscle responds to HIIT by increasing cell size and this hypertrophy occurs between 4 and 8 weeks of the protocol, which is delayed compared to the initiation of myonuclear addition.

Loss of MP fusogenicity at the initiation of HIIT results in exercise intolerance and a failure to hypertrophy {#s2-3}
--------------------------------------------------------------------------------------------------------------

Having established a protocol that leads to myonuclear accretion and myofiber hypertrophy, we next interrogated the role of MP fusogenicity during this physiological exercise regimen. Myomaker (*Mymk*) is an essential factor for fusion of MPs, and we have shown that it is required for growth associated with synergist ablation ([@bib18]). Here we also used *Mymk*^loxP/loxP^; *Pax7*^CreER^ mice to ablate fusion of MPs in an inducible manner prior to HIIT. *Mymk*^loxP/loxP^; *Pax7*^CreER^, and control *Mymk*^loxP/loxP^ mice, were treated with tamoxifen (Tam.) at 8 months of age, and both groups of mice were subjected to HIIT for 8 weeks ([Figure 3A](#fig3){ref-type="fig"}). We refer to *Mymk*^loxP/loxP^; *Pax7*^CreER^ in this set of experiments as Myomaker^scKO\ 8w^ mice because MP fusion was ablated throughout the entire 8 weeks of HIIT. 4 weeks into HIIT it became apparent that Myomaker^scKO\ 8w^ mice were not able to perform and properly adapt to the exercise stimulus. Indeed, quantification of the number of times a mouse landed on the shock grid at the bottom of the treadmill revealed a significant increase in occurrences by Myomaker^scKO\ 8w^ mice, which progressively worsened throughout HIIT ([Figure 3B](#fig3){ref-type="fig"}). We also assessed myonuclear accretion and muscle morphometrics and function in Myomaker^scKO\ 8w^ mice. Single EDL myofibers revealed similar numbers of nuclei between Myomaker^scKO\ 8w^ sedentary and HIIT mice, indicating that myonuclear accretion was effectively blocked ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}). Analysis of muscle weights indicated no increase in size of multiple muscle groups between Myomaker^scKO\ 8w^ sedentary and HIIT mice ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Moreover, histological examination of the gastrocnemius and quadriceps revealed that Myomaker^scKO\ 8w^ mice did not undergo hypertrophy after 8 weeks of HIIT ([Figure 3C](#fig3){ref-type="fig"}). Quantification of myofiber CSA confirmed a lack of HIIT-induced hypertrophy in Myomaker^scKO\ 8w^ mice ([Figure 3D](#fig3){ref-type="fig"}). Of note, we did observe a reduction of CSA in the quadriceps, but not gastrocnemius, of Myomaker^scKO\ 8w^ sedentary mice suggesting a potential role for MP fusion during homeostasis. Finally, we also performed in vivo plantar flexion functional analysis and Myomaker^scKO\ 8w^ HIIT mice did not display an increase in strength compared to Myomaker^scKO\ 8w^ sedentary mice ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Taken together, loss of MP fusogenicity at the onset of HIIT results in exercise intolerance and a failure of the muscle to properly adapt.

![Genetic deletion of Myomaker in muscle progenitors at the onset of HIIT results in exercise intolerance and an absence of hypertrophy.\
(**A**) Illustration of experimental strategy to render muscle progenitors fusion-incompetent prior to HIIT. (**B**) Quantification of the number of times control and Myomaker^scKO\ 8w^ mice visited the shock grid at the bottom of the treadmill to assess the ability to accomplish the exercise protocol. (**C**) Representative sections from the gastrocnemius and quadriceps of control and Myomaker^scKO\ 8w^ mice after HIIT. Sections were immunostained with laminin antibodies and DAPI. (**D**) Quantification of myofiber CSA from the samples in (**C**). Data are presented as mean ± SD. Statistical analyses: (**B**), (**D**) 2-way ANOVA with a Bonferroni correction for multiple comparisons. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001. Scale bars: 100 µm.](elife-44876-fig3){#fig3}

Altered response to HIIT depending on timing of ablation of MP fusogenicity {#s2-4}
---------------------------------------------------------------------------

An inability for Myomaker^scKO\ 8w^ mice to perform HIIT makes it difficult to determine the role of myonuclear accretion for the development of hypertrophy. Since initiation of an exercise regimen can lead to muscle damage that must be repaired to execute future bouts of exercise, and that Myomaker^scKO\ 8w^ mice displayed exercise intolerance 3 weeks into HIIT, we suspected that HIIT may elicit muscle damage that requires MP fusion. Although exercise-induced muscle damage is not well-characterized, especially in comparison to muscle damage as a result of genetic diseases such as muscular dystrophy, release of creatine kinase is a standard assay to measure damage-associated loss of cell membrane integrity. We therefore assessed if HIIT elicited membrane damage that results in release of creatine kinase into the serum. Levels of creatine kinase in the serum of Myomaker^scKO\ 8w^ mice were increased at 2 weeks and 4 weeks of HIIT compared to control mice ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Another defining aspect of exercise is the upregulation of genes in response to mechanical stress due to increased workload and thus we also evaluated expression of mechanical stress genes, including *Ankrd1*, *Ankrd2*, and *Csrp3* ([@bib33]; [@bib3]; [@bib6]). Each of these contractile stress genes were upregulated during HIIT in Myomaker^scKO\ 8w^ mice ([Figure 3---figure supplement 2B, C and D](#fig3s2){ref-type="fig"}). These data indicate that the initial stages of HIIT led to some level of mechanical stress of the muscle, which was subsequently attenuated as part of the normal adaptive response in control mice. Thus, the inability to resolve the initial mechanical stress could account for the exercise intolerance observed in Myomaker^scKO\ 8w^ mice. It should be noted that damage in Myomaker^scKO\ 8w^ HIIT mice was not major enough to elicit functional deficits ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Nonetheless, MP fusion is required to adapt to mechanical damage during the early portion of HIIT, and a failure to repair this damage negatively impacts future bouts of exercise.

To avoid the requirement of MP fusion in the early stages of HIIT, which confounds analysis of hypertrophy at later stages, we treated *Mymk*^loxP/loxP^; *Pax7*^CreER^ with tamoxifen 4 weeks into the HIIT protocol ([Figure 4A](#fig4){ref-type="fig"}). We refer to these mice as Myomaker^scKO\ 4w^ mice because they are fusion-incompetent for the final 4 weeks of HIIT. We first tested if Myomaker^scKO\ 4w^ mice were able to tolerate HIIT and found no difference in treadmill shocks per minute compared to control mice ([Figure 4B](#fig4){ref-type="fig"}). Since Myomaker^scKO\ 8w^ mice exhibited exercise intolerance associated with elevated membrane and mechanical damage, we assessed whether these mice exhibit maladaptive remodeling of muscle, and then compared that response to Myomaker^scKO\ 4w^ mice. We stained histological sections for Masson's Trichrome as an indicator of fibrosis. No evidence of fibrosis was observed in control or Myomaker^scKO^ sedentary mice ([Figure 4C and D](#fig4){ref-type="fig"}). Control HIIT mice also displayed normal muscle architecture with the absence of fibrosis, but Myomaker^scKO\ 8w^ mice exhibited interstitial fibrosis ([Figure 4C and D](#fig4){ref-type="fig"}) indicating that loss of MP fusion early in the HIIT protocol results in maladaptive remodeling. In contrast, no fibrosis was detected in Myomaker^scKO\ 4w^ mice after HIIT showing that loss of MP fusion at this stage does not impact the ability of mice to exercise or result in maladaptive remodeling ([Figure 4C and D](#fig4){ref-type="fig"}). Moreover, these results reveal a direct link between loss of MP fusion in the early stages of HIIT and maladaptive remodeling.

![Loss of muscle progenitor fusogenic ability 4 weeks into HIIT does not affect exercise tolerance or result in maladaptive remodeling.\
(**A**) Schematic showing two different timelines of Myomaker ablation during HIIT. (**B**) Assessment of number of shocks per minute in control and Myomaker^scKO\ 4w^ mice, which reveals that loss of Myomaker 4 weeks into HIIT had no impact on exercise tolerance. (**C**) Masson's trichrome staining shows that ablation of Myomaker at the beginning of HIIT (Myomaker^scKO\ 8w^) results in fibrosis indicating maladaptive remodeling. Evidence of fibrosis was not detected when Myomaker was deleted 4 weeks into HIIT (Myomaker^scKO\ 4w^). (**D**) Quantification of fibrotic area from the samples shown in (**C**). Data are presented as mean ± SD. Statistical analysis: (**D**) 1-way ANOVA with a Tukey correction for multiple comparisons. \*\*\*\*p\<0.0001 compared to all other groups. Scale bar: 200 µm.](elife-44876-fig4){#fig4}

Given that Myomaker^scKO\ 4w^ mice exercised normally, and that HIIT-induced hypertrophy in control mice developed between 4 and 8 weeks of the protocol, we sought to determine if muscle growth was affected after ablation of MP fusion at late stages of HIIT ([Figure 5A](#fig5){ref-type="fig"}). Analysis of myofiber size in the gastrocnemius and quadriceps of control mice subjected to HIIT displayed the expected 15--20% increase, however Myomaker^scKO\ 4w^ muscle failed to hypertrophy ([Figure 5B and C](#fig5){ref-type="fig"}). To confirm that MP fusion at 4 weeks of HIIT indeed resulted in reduced myonuclear accretion we assessed myonuclear numbers in isolated Myomaker^scKO\ 4w^ EDL myofibers ([Figure 5D](#fig5){ref-type="fig"}). Compared to control mice that performed HIIT we observed a significant reduction of myonuclei in Myomaker^scKO\ 4w^ myofibers, which reached the level of myonuclei in control mice at 4 weeks of HIIT ([Figure 5E](#fig5){ref-type="fig"}). This indicates that further myonuclear accretion was blocked soon after the 4 week time point in Myomaker^scKO\ 4w^ muscle. We also assessed myofiber volume in EDL myofibers and observed larger myofibers in control HIIT compared to sedentary mice but did not detect any volume increase in Myomaker^scKO\ 4w^ myofibers ([Figure 5F](#fig5){ref-type="fig"}). Taken together, HIIT-induced muscle growth requires MP fusion throughout the exercise protocol. While this indicates a tight relationship between myonuclear numbers and adaptive growth, it also raises the intriguing possibility that the mechanistic requirement for fusion at the later stages of HIIT is independent, and potentially distinct, from the need for accrual in the earlier stages that involve injury and repair.

![Myonuclei added over the final 4 weeks of HIIT are required for HIIT-induced hypertrophy.\
(**A**) Schematic showing how Myomaker^scKO\ 4w^ mice were generated. (**B**) Representative sections of gastrocnemius and quadriceps from control sedentary (Sed.), control HIIT, or Myomaker^scKO\ 4w^ HIIT mice. Sections were immunostained with laminin antibodies and DAPI. (**C**) Quantification of myofiber CSA from the samples in (**B**) showing that Myomaker^scKO\ 4w^ myofibers fail to hypertrophy. (**D**) Individual myofibers from EDL demonstrating that Myomaker^scKO\ 4w^ HIIT mice do not recruit as many myonuclei as control HIIT mice. (**E**) Quantification of myonuclei per myofiber from the samples in (**D**). The dotted line indicates the average myonuclear number of nuclei in WT myofibers after 4 weeks of HIIT (from [Figure 2A](#fig2){ref-type="fig"}) demonstrating that Myomaker^scKO\ 4w^ HIIT mice fail to add new myonuclei after this time. (**F**) Assessment of myofiber volume in isolated EDL myofibers confirms WT HIIT-trained muscle undergoes hypertrophy, but this does not occur in Myomaker^scKO\ 4w^ mice. Data are presented as mean ± SD. Statistical analyses: (**C**), (**F**) 1-way ANOVA with a Tukey correction for multiple comparisons, (**E**) unpaired two-tailed Student's t-test. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001. Scale bars: 100 µm.](elife-44876-fig5){#fig5}

One interpretation for the inability for Myomaker^scKO\ 4w^ muscle to grow is that loss of MP fusogenicity has an acute effect on the growth potential of myofibers. To address this concern, we employed a pharmacologic approach to drive hypertrophy through manipulation of myostatin signaling, which is a negative regulator of muscle mass ([@bib25]). We first treated *Mymk*^loxP/loxP^ or *Mymk*^loxP/loxP^; *Pax7*^CreER^ mice with tamoxifen at 3 months of age, to generate control and Myomaker^scKO^ animals, respectively. Three days after the final tamoxifen dose we administered PBS or a soluble form of one of the myostatin receptors (activin type IIB) where the extracellular domain was fused to a Fc domain (ACVR2B-Fc) ([@bib27]; [@bib26]). Mice were treated weekly over 4 weeks and then muscle was harvested for assessment of hypertrophy ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Histological analysis revealed an increase in myofiber size in both control and Myomaker^scKO^ mice that received ACVR2B-Fc ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Assessment of muscle weights normalized to tibia length in ACVR2B-Fc-treated animals, as a percentage of their respective PBS-treated controls, also showed that Myomaker^scKO^ muscle possesses the ability to grow in response to pharmacologic stimuli ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Muscle growth driven by myostatin inhibition in the absence of MP fusion ability, further indicates that the reason underlying a lack of hypertrophy in HIIT-trained Myomaker^scKO\ 4w^ muscle is due to deficient myonuclear accretion in the final stages of exercise.

Discussion {#s3}
==========

In this study we evaluated the role of MP fusogenicity and associated myonuclear accretion during physiological exercise. Since the most often used exercise stimulus for mice, voluntary wheel running, does not lead to consistent hypertrophy we developed a HIIT protocol by exposing mice to a progressive increase in the amount of work performed through adjusting either the treadmill incline or speed over 8 weeks. We observed an increase in myonuclear numbers at each stage of HIIT indicating that MP fusion occurs throughout the exercise regimen. HIIT resulted in a 16% increase in myofiber CSA in the gastrocnemius and a 21% increase in the quadriceps, which developed between 4 and 8 weeks of the protocol. Ablation of MP fusion either at the onset of, or 4 weeks into, HIIT produces divergent observations with important ramifications. Absence of MP-derived Myomaker at the beginning of HIIT resulted in an inability to withstand the exercise stimulus, development of maladaptive remodeling, and lack of adaptive hypertrophy, whereas deletion of Myomaker 4 weeks into HIIT mainly impacted hypertrophy.

The requirement of MuSCs for myofiber hypertrophy has been debated for decades ([@bib44]; [@bib37]; [@bib8]; [@bib40]). Genetic perturbations of MuSCs and their MP descendants offer the most direct assessment of their role during muscle growth, but results have not led to a consensus paradigm. Ablation of MuSCs with a DTA allele in 4 month-old mice, which would inhibit the potential to generate fusogenic MPs, was initially reported to not impact the ability for myofibers to hypertrophy after synergist ablation, leading to the idea that MuSCs were dispensible ([@bib29]). This experiment was repeated by an independent group that antithetically found MuSC-ablated muscle was unable to hypertrophy in 3--4 month-old-mice ([@bib15]). We also performed synergist ablation on fusion-incompetent mice (through deletion Myomaker in MPs) at 3--4 months of age and found an absolute requirement of MP fusogenicity for growth ([@bib18]). Moreover, another study confirmed the requirement of MuSCs for overload-induced hypertrophy in 3 month old mice through genetic deletion of serum response factor (Srf), which is required for fusion ([@bib42]). Current ideas to explain the discrepancies are that young mice (younger than 4 months of age) are reliant on MP fusogenicity for growth but older myofibers can hypertrophy in the absence of new myonuclei ([@bib36]). Recent evidence claims an age-dependence on MuSCs as ablation of MuSCs at 4 weeks of age reduces normal developmental hypertrophy ([@bib1]), while loss of MuSCs in the adult has minimal effects in sedentary mice ([@bib17]; [@bib22]). We show here that ablation of MP fusion at the onset of HIIT in 8-month-old mice results in exercise intolerance and fibrosis. Since synergist ablation is a stronger stimulus compared to HIIT, we think it is unlikely that Myomaker^scKO^ mice at 8 months of age would be able to properly adapt to synergist ablation. Overall, our data indicates that age dependence may not sufficiently explain the discrepancy about the role of MuSCs for synergist ablation-induced hypertrophy in mice that are 3--4 months of age.

Myonuclear accretion during HIIT is continuous where approximately 25 myonuclei per myofiber are added within the first 2 weeks, another 25--30 myonuclei between 2 and 4 weeks, and then 25 myonuclei over the final 4 weeks. While myonuclear number increases throughout HIIT, growth of myofibers occurred between 4 and 8 weeks indicating that myonuclear accretion precedes detectable growth. This is consistent with the response of muscle to synergist ablation where myofibers acquire new nuclei before an increase in size ([@bib5]). Our data not only demonstrate the persistent nature of myonuclear accrual during exercise, but we also shed light on whether myofibers require new nuclei throughout the protocol to grow. Ablation of Myomaker in MPs 4 weeks after HIIT resulted in a failure to hypertrophy even though this only corresponds to a lack of 25 myonuclei. These data show that the addition of 50--55 myonuclei added during the initial 4 weeks of HIIT are not sufficient to drive adaptive hypertrophy. Thus, a key finding from our work is that HIIT-induced adaptive growth requires continued myonuclear accrual throughout the protocol.

Exercise-induced adaptations involve the response to myofiber damage, increased contractile output, and growth of the myofiber, but it has been difficult to ascertain if myonuclear accrual is required for each of these adaptations. Surprisingly, the HIIT protocol described here may have uncoupled these adaptive processes since there are multiple lines of evidence suggesting distinct phases (mitigation of injury and growth) during HIIT. First, we show that muscle damage (assessed by levels of serum creatine kinase and contractile stress genes) is a normal response to HIIT and these damage markers progressively diminish over the duration of the protocol. If fusion is abrogated at the onset of HIIT (Myomaker^scKO\ 8w^), mice are unable to repair HIIT-induced muscle damage, which causes exercise intolerance. However, when mice are allowed to accumulate new nuclei into the myofiber (approximately 50--55) during the first four weeks but further MP fusion is blocked (Myomaker^scKO\ 4w^), the mice are able to exercise normally indicating that the damage phase of exercise has been mitigated. These data are generally consistent with reports in humans that resistance training causes early increases in protein synthesis to support tissue repair but does not correlate with hypertrophy, which occurs only after the repair of damage ([@bib9]; [@bib32]; [@bib34]).

What could explain the observation that Myomaker^scKO\ 4w^ mice are able to exercise normally during the final four weeks of HIIT? One possibility is that the nature of the stimulus changed from a gradual increase in treadmill incline in the first four weeks to an increase in speed (with constant incline) over the next four weeks. One argument against this possibility is that Myomaker^scKO\ 8w^ mice exhibit progressive failure to exercise even after the protocol changed. A limitation of our study is that we did not test if Myomaker^scKO\ 4w^ mice eventually become exercise intolerant by extending the exercise protocol or performing an acute treadmill run-to-exhaustion test. Another possibility that could explain the ability for Myomaker^scKO\ 4w^ mice to exercise is that nuclei added during the first four weeks of HIIT still support the reparative response in the final four weeks of HIIT, which allows them to tolerate the exercise.

Since Myomaker^scKO\ 4w^ mice exercise normally during the final four weeks of HIIT and have accumulated 50--55 new nuclei/fiber, why do they not undergo muscle hypertrophy? This question is currently difficult to answer but dogma would argue that Myomaker^scKO\ 4w^ muscle has not accumulated enough myonuclei to grow. Perhaps there is a tight correlation between absolute myonuclear numbers and growth potential, with minimal tolerance for reduced numbers. A more provocative explanation is that the added myonuclei may be assigned specialized roles depending on the stage of adaptation. In this scenario, the 25 new myonuclei added in the final 4 weeks of HIIT are specialized for growth whereas the 50--55 myonuclei added in the first 4 weeks of HIIT are mainly utilized for repair of tissue injury. Adding support to such an idea of specialized roles of accrued myonuclei is that our data also reveal a potential lack of redundancy within the population of the newly accrued nuclei, given the apparent inability of the 50--55 nuclei added early in HIIT to compensate for the lack of 25 nuclei late in HIIT to drive growth. The two ideas discussed here, that there is a threshold of myonuclear number that must be met for growth and the potential for myonuclear functional heterogeneity, are not necessarily inconsistent with each other. More specifically, it is possible that there is a tight correlation of myonuclear number for growth because new nuclei specialized for growth are required, thereby increasing overall myonuclear numbers. Precise mechanisms by which myofibers utilize the new nuclei during various stages of adaptation warrants further investigation.

The importance of myonuclear accretion has classically been viewed through the lens of the myonuclear domain theory, which postulates that a given myonucleus controls a certain volume of cytoplasm ([@bib38]), and that for muscle to grow it needs more nuclei to support the larger cellular volume. We propose that the myonuclear domain theory may be too simplistic to explain the complexity of muscle adaptability. A major issue with the myonuclear domain theory is that it links myonuclear numbers solely with growth. In doing so, it assumes all myonuclei, freshly accrued or added during development, are homogenous in terms of both magnitude and profile of transcriptional activity. However, myonuclei possess the ability to alter transcription in the absence of MuSCs suggesting a dynamic, heterogenous system ([@bib24]). Our data reveals that myonuclear accrual extends beyond just the maintenance of the myonuclear domain. Indeed, MP fusion and myonuclear accrual are essential for normal exercise-related adaptive responses that encompass both repair and growth, which has implications for maintaining muscle mass during disease and aging.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                   Designation         Source\             Identifiers   Additional\
  (species) or\                                       or reference                      information
  resource                                                                              
  ------------------------------- ------------------- ------------------- ------------- ---------------------------------------------------------------------
  Genetic reagent (M. musculus)   *Mymk*^loxP/loxP^   [@bib31];[@bib18]                 Dr. Douglas Millay (Cincinnati Children\'s Hospital Medical Center)

  Genetic reagent (M. musculus)   *Pax7*^CreER^       [@bib28]                          Dr. Chen-Ming Fan (Carnegie Science)

  Peptide, recombinant protein    ACVR2B-Fc           [@bib27]                          Dr. Se-Jin Lee (The Jackson Laboratory)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

*Mymk* mouse strains used in this study have been described previously ([@bib18]; [@bib31]). Briefly, fusion-incompetent mice (Myomaker^scKO^) were generated by breeding *Mymk*^loxP/loxP^ mice with satellite cell-specific (*Pax7*^CreERT2^) Cre recombinase mice ([@bib28]), while *Mymk*^loxP/loxP^ mice served as controls. All experiments were performed on male mice. All animal procedures were approved by Cincinnati Children's Hospital Medical Center's Institutional Animal Care and Use Committee (IACUC2017-0053).

Tamoxifen treatment {#s4-2}
-------------------

Tamoxifen (TAM; Sigma-Aldrich) was mixed in corn oil with 10% ethanol at 25 mg/ml. Prior to initiation of 8 weeks of HIIT, 8 month old mice were administered five daily doses of TAM at 0.075 mg/g/day through intraperitoneal injections (Myomaker^scKO\ 8w^). In a second group of 8 month old mice, TAM treatment was delayed, and the five daily doses were administered after the 4^th^ week of HIIT (Myomaker^scKO\ 4w^). After initial TAM dosing, all mice received a weekly TAM injection for the remaining duration of the HIIT protocol. For the ACVR2B-Fc study, 3 month old mice were subjected to five daily doses of TAM 3 days prior to administration of ACVR2B-Fc, and maintained on a TAM regimen (injections every three days) for 4 weeks.

High-intensity interval training (HIIT) {#s4-3}
---------------------------------------

We modified a recently reported high-intensity interval training protocol (HIIT) for aged mice ([@bib43]). Our 8 week HIIT protocol was designed to increase the amount of work performed each week. For the first 4 weeks of HIIT, there was a weekly 5^o^ increase in the angle of inclination from 10° at week 1 up to 25° at week 4. Treadmill speed was maintained at 15 m/min for this duration. From weeks 5--8, treadmill speed was increased by 1 m/min weekly to a maximum speed of 20 m/min at week 8, while the angle of inclination was maintained at 25°. Using the equation developed previously (Work (J) = body mass (kg) x gravity (9.81 m/sec^2^) x vertical speed (m/sec x angle) x time (sec)) ([@bib39]) to determine the amount of work performed (J), we established that our HIIT protocol results in a weekly increase of 5--15% in work.

Prior to HIIT, mice were acclimated on the treadmill three times a week at a speed of 8 m/min for 15 min with no incline. After a week of acclimation, mice were subjected to 3 sessions of HIIT per week for 8 weeks. Each session consisted of a 5 min warm-up at 8 m/min, eight exercise intervals at the prescribed speed and angle of inclination for 3--5 min, and a 1 min rest interval at 8 m/min between each exercise interval. As a negative reinforcement, mice that were unable to stay on the treadmill were shocked by an electric stimulus emanating from a shock grid located at the back of the treadmill. The electric stimulus was set at a current of 1 mA and a repetition rate of 2 Hz. At the last HIIT session of each week, exercise tolerance in each mouse was assessed by counting the number of times the mouse landed on the shock grid. Each mouse was visually observed for at least 5 min for this purpose. To ensure mice could meet the demands of the protocol, we established an exclusion-criteria based on the inability of the mouse to recover following electric shock exposure. Mice were given 5 s to resume running after landing on the shock grid; those that remained on the shock grid for more than 5 s were manually assisted back on the treadmill. If such assistance occurs more than twice during an exercise interval, the mouse is excluded from treadmill running for the duration of that interval. An exclusion from two exercise intervals in the same HIIT session would result in the mouse being excluded from the remainder of the session. Finally, an exclusion from more than 2 HIIT sessions resulted in expulsion from the study and no data from these mice were used for analysis. Based on this exclusion criteria, we had to remove 1 Control mouse, 3 Myomaker^scKO\ 8w^, and 0 Myomaker^scKO\ 4w^ mice. All HIIT sessions were performed on an Exer 3/6 Treadmill from Columbus Instruments.

Inhibition of myostatin signaling {#s4-4}
---------------------------------

Inhibition of myostatin/activin A signaling, a potent negative regulator of muscle mass, was achieved by a pharmacological approach previously described by others ([@bib27]). Briefly, robust muscle hypertrophy was induced by utilizing a soluble form of the activin type IIB receptor where the extracellular ligand binding domain has been fused to an Fc domain (ACVR2B-Fc), effectively rendering it as a decoy receptor for myostatin. 3 month old mice were given four weekly doses of PBS or ACVR2B-Fc at 10 mg/kg through intraperitoneal injections 3 days after the last dose of TAM was administered.

In vivo muscle force measurements {#s4-5}
---------------------------------

Following 8 weeks of HIIT, the strength of plantar flexor muscles was evaluated by in vivo isometric tetanic force measurements. Mice were placed under anesthesia with 2% isoflurane inhalation, then the right knee was fixed on a clamp, and the right foot secured at a 90° angle on the pedal of a dual-mode servometer (300C-LR: Aurora Scientific, Aurora, ON, Canada). To stimulate the tibia nerve, needle electrodes connected to an electric stimulator (701C: Aurora Scientific, Aurora, ON, Canada) were inserted in the posterior knee. Isometric twitch force (Pt) was generated by a 0.2 ms pulse with 50 mA to find the optimal muscle length. Maximum isometric tetanic force (Po) of the plantar flexor muscles was subsequently evaluated by a 0.2 ms pulse for 350 ms at a frequency of 50 to 150 Hz. A two-minute rest was allowed between each tetanic contraction. All force measurement data was collected by Dynamic Muscle Control (DMC v5.5) and analyzed based on the tetanic force graph by Dynamic Muscle Analysis (DMA v5.3), which yielded peak tetanic force, rate of force activation and relaxation, and impulse achieved during a tetanic contraction.

Muscle collection and preparation {#s4-6}
---------------------------------

Quadriceps, gastrocnemius, tibialis anterior (TA), and extensor digitorum longus muscles (EDL) were dissected, blotted dry, and weighed. Hindlimbs were dissolved overnight in lysis buffer containing 0.4 mg/ml proteinase K (Sigma Aldrich \#03115879001) at 55°C. Tibia length was assessed by a digital caliper, and the average of three measurements was recorded. For histological sections, muscles were embedded in OCT compound (gastrocnemius and quadriceps) or 1% tragacanth/PBS (TA) and frozen in liquid nitrogen-cooled 2-methylbutane for cryosections, or embedded in warm paraffin wax (gastrocnemius) for paraffin sections that were stained with Masson's Trichrome. Sections were then cut at 10 µm. For gene expression analysis, quadriceps were flash-frozen in liquid nitrogen and stored at --80°C. For single fiber analysis, whole EDL muscles were incubated in 0.2% Type I collagenase (Sigma-Aldrich \#C-0130) in DMEM (Hyclone) for 1 hr at 37°C, and then transferred to DMEM containing 10% horse serum and triturated to release individual fibers.

Histological analyses and serum creatine kinase {#s4-7}
-----------------------------------------------

Cryosections were fixed in 1% PFA/PBS, permeabilized with 0.2% Triton X-100/PBS, blocked with 1% BSA/PBS/1% heat-inactivated goat serum/0.025% Tween20/PBS, and incubated with primary antibody overnight at 4°C. Following 1 hr of incubation with a secondary Alexa Fluor antibody (1:200) (Invitrogen), slides were mounted with VectaShield containing DAPI (Vector Laboratories). For assessment of hypertrophy, samples were stained with anti-laminin (1:100; Sigma-Aldrich \# L9393), and myofiber cross-sectional area (CSA) was visualized and quantified as described previously ([@bib18]). To assay for myonuclear number, samples were stained with anti-dystrophin (1:100; Abcam \#ab15277), and visualized at 40x on a Nikon A1R + LUNV on a Ti-E Inverted Microscope. The total number of DAPI^+^ nuclei within a dystrophin-stained myofiber was quantified. Myonuclear accretion was also assessed in single EDL myofibers. Isolated fibers were fixed in 4% PFA/PBS for 30 min at 4°C, washed three times in PBS, permeabilized with 0.2% Triton X-100/PBS and mounted with Vectashield containing DAPI. 10x optical sections were generated on a Nikon Ti-E SpectraX widefield microscope, and the total number of DAPI^+^ nuclei along the entire length of a myofiber was quantified with a spot detection algorithm developed in Imaris (Bitplane). To quantify the size of a single fiber, length and radius measurements were performed in Imaris, and muscle volume was calculated. For assessment of fibrosis, Masson's Trichrome staining was performed on paraffin sections using standard protocols. Fibrotic area within a section was visualized at 20x with an Olympus BX51 inverted microscope, and quantified with a binary thresholding algorithm from Imaris (Bitplane). Blood was harvested from the inferior vena cava of anesthetized mice, then submitted to the clinical laboratory at Cincinnati Children's Hospital Medical Center for analysis of creatine kinase in the serum.

RNA analysis {#s4-8}
------------

Total RNA was extracted from quadriceps muscle with Trizol (Invitrogen), and cDNA was synthesized using MultiScribe reverse transcriptase with random hexamer primers (Applied Biosystems). Expression of contractile stress genes was assessed using standard qPCR approaches with PowerUp SYBR Green Master Mix (Applied Biosystems). Analysis was performed on a 7900HT fast real-time PCR machine (Applied Bio-systems) with the following primers: *Ankrd1* (Forward, 5'-GGATGTGCCGAGGTTTCTGAA-3' and Reverse, 5'-GTCCGTTTATACTCATCGCAGAC-3'); *Ankrd2* (Forward, 5'-TGGACATGCTAGTGCTAGAGG-3' and Reverse, 5'-CGCTTTTTCTGCTTGCGTTTT-3'); *Csrp3* (Forward, 5'-TCTACTGTAAGGTGTGCTATGGG-3' and Reverse, 5'-GCTTTGGGGATTGTTGGAACTG-3'). *GAPDH* primers (Forward, 5'-TGCGACTTCAA-CAGCAACTC-3' and Reverse, 5'-GCCTCTCTTGCTCAGTGTCC-3') were used as internal controls.

Statistical analysis {#s4-9}
--------------------

All quantitative data sets that contained at least four samples were initially assessed with a Shapiro-Wilk normality test to determine distribution of values. Differences in values between two data sets were analyzed with an unpaired two-tailed Student's *t*-test (normal distribution) or Mann-Whitney rank sum test (non-normal distribution) using GraphPad Prism 7.0 software. We determined variance for each data set with a F test and all data sets showed equal variance, therefore tests to correct for unequal variance were not needed. For multiple data sets with one independent variable, a 1-way ANOVA with Tukey correction for multiple comparisons was performed. For data sets with two independent variables, a 2-way ANOVA with Bonferroni correction for multiple comparisons was performed. Statistical significance was set at a P value \< 0.05. For assessments of size (myofiber CSA and single fiber muscle volume), total nuclei (cross-sections and single fibers), and fibrosis, data analyses were performed in a blinded fashion. All data sets are presented as means ± SD, and the degree of significance between data sets is depicted as follows: \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Myonuclear accretion is a determinant of exercise-induced remodeling in skeletal muscle\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Sean Morrison as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Gabrielle Kardon (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript from Goh et al. directly addresses a fundamental controversy on how muscle mass is built. More specifically if fusion of activated satellite cells (MP) are mandatory for hypertrophy. Reviewers felt that the approaches are unique and definitive. While there is excitement for the manuscript, there was a concern regarding the number of mice used in some of the experiments, During the discussion between the BRE and reviewers, it was felt that increasing the numbers of mice in these data sets would be desirable-if they are available. If not, more careful use of the statistics and more cautious conclusions.

Below are the main points to consider. These points are given more context within the reviewers individual comments.

1\) The major weakness of the study is that the number of observations is low (down to 3), and some of the results therefore need to be interpreted with caution. Can more mice be included into specific experiments?

2\) The authors make conclusions regarding the phases (first 4 weeks versus 2nd 4 weeks) of HIIT, but there may be an alternative interpretation. Could these be different responses to increasing incline versus increasing speed?

3\) The authors discuss muscle damage a lot, but the molecular data they provide (Figure 3---figure supplement 2) is not really on molecules related to damage or repair/regeneration: heat-shock proteins, embryonal myosin or creatine kinase would be beneficial.

4\) Clarification and caution in the Discussion.

*Reviewer \#1:*

This is a very interesting paper that deal with some of the fundamental controversies on how muscle mass is built. More specifically, if fusion of activated satellite cells (MP) are mandatory for hypertrophy. There have been two major caveats in this debate, one is that most of the conclusions are based on supra-physiological overload by surgical ablation of synergists. The other is a current perception that only in animals less than 4 months of age muscle hypertrophy is dependent on MP fusion. The current paper resolves both these questions: animals of 8 months of age subjected to a physiological high intensity training protocol displayed significant hypertrophy, while when MP fusion was prevented, hypertrophy was also prevented. In my opinion these are the most interesting findings, but the paper also demonstrated that when MP fusion was prevented at the onset of exercise the animals were unable to fulfil the exercise task and muscle fibrosis was also induced. If the fusion was prevented only after the initial exercise phase these phenomena did not occur, but hypertrophy was still largely prevented.

A particular strength, is that the authors has dealt elegantly with the problem of the transgenic animals not performing well on the exercise task and that they displayed fibrosis.

The major weakness of the study is that the number of observations is low (down to 3), and some of the results therefore need to be interpreted with caution. The statistics should be improved or at least be described better. The authors might benefit from consulting a statistician.

Another weakness is the Discussion seems to create strawmen that the authors argue against, the Discussion should be rewritten.

Specific points:

Statistics

The authors use a mix of parametric and non-parametric testing, they need to make clear what the criteria for selecting each method was, and which p-values are derived from which method (for example in the legends).

Is it possible to determine from 3 observations if they are normally distributed or not?

Should non-parametric testing be accompanied with median and percentiles rather than mean an SD?

There seems not that much difference in variance between groups, why was Welch test used?

How about corrections for multiple comparisons?

Would the time courses be better tested by using nested ANOVA, two-way ANOVA or a linear mixed analysis?

Results

The authors discuss muscle damage a lot, but the molecular data they provide (Figure 3---figure supplement 2) is not really on molecules related to damage or repair/regeneration but rather to mechanical stress which might not always damage. If the authors still have extracts of muscles, they should be able to measure more relevant molecules such as heat-shock proteins or embryonal myosin (the latter can also be analysed on cryosections). It would also be useful if they could compare such markers between control and experimental groups, e.g. is the level higher in the mice that were tamoxifen injected at the onset than for other groups (controls and late injected.

Discussion

As mentioned, I find large parts of the Discussion problematic, for example:

\"Exercise-induced adaptations involve the response to myofiber damage, increased contractile output, and growth of the myofiber, but it has been difficult to ascertain if myonuclear accrual is required for early exercise-related injury alone, adaptive growth alone, or both.\"

I have never seen anybody suggest that myonuclear accrual should not be related to repair of injury. Very unclear statement, rephrase.

\"Surprisingly, the HIIT protocol described here uncoupled these adaptive processes.\"

I am not sure the data really show this. You would need to explain better or delete.

\"We observed an increase in myonuclear numbers at each stage of HIIT indicating that MP fusion occurs and that accrual is not a consequence of a single event.\"

I am not sure I understand this. What single event? Do you mean onset of exercise? I would interpret the data to mean that there is a gradual increase in the number of nuclei with a somewhat lagging increase in CSA during exercise. Bruusgaard et al., 2010 showed by overload that the MP fusion seemed to precede the CSA growth, and thus hinting on a causal relationship. When the authors here state \"It is interesting to consider that in WT mice myonuclear accretion occurs throughout HIIT but hypertrophy transpires at later stages.\" It sounds like a similar conclusion. Could the authors plot the data in a better way illustrating this point?

\"This suggests that an increase in myonuclei does not necessarily indicate that hypertrophy is forthcoming, which could explain the inconsistencies of studies reporting a correlation between myonuclear number and myofiber size and other studies finding no correlation (Murach et al., 2018; Damas et al., 2018).\"

I don\'t understand this argument. I have not seen anybody suggest that an increase in myonuclei is in itself is sufficient to induce hypertrophy. As I understand it the general idea has been that more myonuclei might be required for hypertrophy, but that some hypertrophic signal (for example load) is also required. For example, inactive nulei-rich fibres will also atrophy if denervated. I also don\'t understand how the findings of Murach et al., 2018 (is a review not a study) and Damas et al., 2018, could be explained in this way?

\"Since our data indicate that evidence of myonuclear accretion cannot be used simply to predict myofiber size, we propose that addition of myonuclei may serve specialized roles depending on the stage of adaptation. For instance, myonuclei could be recruited to the myofiber during exercise initiation to allow adaptation to moderate damage whereas myonuclear accretion at the later stages of HIIT could facilitate adaptive hypertrophy. Collectively, these observations agree with reports in humans that resistance training-induced hypertrophy occurs after suppression of damage (Damas et al., 2016)\".

My interpretation would be that muscle fibres without new nuclei don\'t increase sufficiently in size and/or strength to cope with the forced HIIT and some of the fibres are ruptured. Muscle damage in untrained people that start to exercise abruptly and hard is well known (rhabdomyolysis), and here electroshock is used. I don\'t think this translates to specialized roles for nuclei depending on stage of adaption or that early accretion is necessarily related to damage. Has damage been observed in the control mice here? The title of Damas et al., 2016, rephrased here is misleading. As I understand it, the authors of that paper did not really suppress damage, they just compared synthesis during early phases with lots of repair and later phases with less repair and more radial growth. If this part is to be kept in the Discussion the relevance to the present paper needs to be explained better.

*Reviewer \#2:*

Muscle stem cells, known as satellite cells, are well known to be required for regeneration after acute muscle damage. However, the role of satellite cells during muscle hypertrophy has been controversial. Most studies using mouse to examine the contribution of satellite cells during hypertrophy have genetically ablated satellite cells, using Pax7^CreERT2^/+;RosaDTA/+ mice, in the context of synergistic ablation. However, synergistic ablation may not be physiologically relevant to exercise-induced hypertrophy and satellite cell ablation may have unknown consequences on the molecular and cellular characteristics of the myofiber (for instance, if the myofiber somehow can \"sense\" the presence of satellite cells and so the absence of satellite cells may change the myofiber characteristics). This manuscript from the Millay lab takes a new approach toward interrogating the role of satellite cells in muscle hypertrophy. First, they develop a new system to induce muscle hypertrophy in mice: 8 month old mice are subject to running 3x/week (at 15-16 meters/minute) on a treadmill in which the incline angle progressively increases (10o, 15o, 20 o, and 25 o) during the first 4 weeks and then the treadmill speed increases progressively (17, 18, 19, and 20 m/min) during the final 4 weeks. Second, in experimental mice they specifically prevent fusion of satellite cells to the myofibers using the tightly controlled Pax7^CreERT2^/+;*Mymk*^loxP/loxP^, in which Myomaker (required for fusion) is deleted inducibly in satellite cells. Using these two techniques. they gain unique insights into the role of satellite cells in hypertrophy. First, they find that their High Intensity Interval Training (HIIT) protocol does indeed lead to myofiber hypertrophy during 4-8 weeks of HIIT (as measured by an increase in myofiber cross-sectional area of 4 different leg muscles) with increased muscle strength and this is accompanied by an increase in myonuclei/myofiber (as measured in EDL and Quadriceps muscles). Second, deletion of Myomaker in satellite cells did indeed abrogate myonuclear accretion, and loss of myomaker and myonuclear accretion throughout the 8 week HIIT inhibited the mice\'s ability to perform and adapt to exercise stimulus (beginning at 3 weeks of HIIT). Third, based on measurements of Ankrd1/2 and Crsp3 the HIIT protocol resulted in transitory myofiber damage at 2 weeks of HIIT. Fourth, inhibition of satellite cell fusion for the entire 8 weeks of HIIT resulted in an increase in fibrosis. However, inhibition of satellite cell fusion beginning at 4 weeks of HIIT did not result in fibrosis or impair the ability of mice to exercise, but led to myofiber failure to hypertrophy. Fifth, even in the absence of satellite cell fusion to myofibers, myofibers are able to hypertrophy in response to myostatin inhibitors. Together these data suggest the following model. Satellite cells contribute to myofibers throughout the HIIT protocol, but only after 4 weeks of HIIT do myofibers hypertrophy. Based on the comparison of inhibition of satellite cell fusion throughout the 8 weeks of HIIT versus 4-8 weeks of HIIT, they conclude that satellite cell fusion during the first 4 weeks is necessary to prevent fibrosis and to ensure adaptation to exercise stimulus, while satellite cell fusion after 4 weeks enables myofiber hypertrophy. Thus they argue that the initial phase of satellite cell recruitment is to necessary to tolerate exercise stimulus, mitigate stress during the initial stages of HIIT, and prevent fibrosis, while the later phase of satellite cell recruitment is necessary for myofiber hypertrophy. Overall, this is a well-executed study that is clearly documented and explained and contributes to our knowledge of how satellite cells contribute to muscle hypertrophy.

1\) I have only one substantive comment about the paper. The authors argue that the satellite cell contribution to myofibers during the first 4 weeks of HIIT serves a fundamentally different function than satellite cell contribution to myofibers during 4-8 weeks of HIIT. However, during the first 4 weeks of HIIT the mice were subjected to an increasing incline, while during the last 4 weeks the mice were subjected to increasing speed. Isn\'t the most parsimonious explanation of the difference in the function of satellite cell contribution during the first versus the second four weeks simply that these are different responses to increasing incline versus increasing speed? Would they see a difference if they simply increased monotonically either the incline or the speed throughout the 8 week HIIT? I do not propose that they re-do these experiments, but I think how to interpret the effects of inhibiting satellite cell fusion throughout the 8 weeks versus just the last 4 weeks of HIIT is unclear. At a minimum, the authors need to explicitly discuss this.

10.7554/eLife.44876.015

Author response

> Summary:
>
> The manuscript from Goh et al. directly addresses a fundamental controversy on how muscle mass is built. More specifically if fusion of activated satellite cells (MP) are mandatory for hypertrophy. Reviewers felt that the approaches are unique and definitive. While there is excitement for the manuscript, there was a concern regarding the number of mice used in some of the experiments, During the discussion between the BRE and reviewers, it was felt that increasing the numbers of mice in these data sets would be desirable-if they are available. If not, more careful use of the statistics and more cautious conclusions.
>
> Below are the main points to consider. These points are given more context within the reviewers individual comments.
>
> 1\) The major weakness of the study is that the number of observations is low (down to 3), and some of the results therefore need to be interpreted with caution. Can more mice be included into specific experiments?

We increased the number of animals to at least n=4. Moreover, a post-hoc power analysis revealed that each significant difference detected is sufficiently powered (power of at least 80%).

> 2\) The authors make conclusions regarding the phases (first 4 weeks versus 2nd 4 weeks) of HIIT, but there may be an alternative interpretation. Could these be different responses to increasing incline versus increasing speed?

This is an excellent point by the reviewers and one in which we have considered. Our Discussion has been amended to include this possibility.

> 3\) The authors discuss muscle damage a lot, but the molecular data they provide (Figure 3---figure supplement 2) is not really on molecules related to damage or repair/regeneration: heat-shock proteins, embryonal myosin or creatine kinase would be beneficial.

We analyzed creatine kinase in the serum of WT and Myomaker^scKO\ 8w^ mice (+/- HIIT) as a marker of muscle injury/damage. We found evidence for muscle damage in WT mice after 2w and 4w of HIIT, and this was increased in Myomaker^scKO\ 8w^ mice. These data demonstrate that HIIT is associated with some level of muscle damage, which is exacerbated when fusion of muscle progenitors is blocked.

> 4\) Clarification and caution in the Discussion.

We overhauled the Discussion as suggested.

> Reviewer \#1:
>
> \[...\] Statistics
>
> The authors use a mix of parametric and non-parametric testing, they need to make clear what the criteria for selecting each method was, and which p-values are derived from which method (for example in the legends).
>
> Is it possible to determine from 3 observations if they are normally distributed or not?
>
> Should non-parametric testing be accompanied with median and percentiles rather than mean an SD?
>
> There seems not that much difference in variance between groups, why was Welch test used?
>
> How about corrections for multiple comparisons?
>
> Would the time courses be better tested by using nested ANOVA, two-way ANOVA or a linear mixed analysis?

We thank the reviewer for these accurate criticisms and based on the comments we improved the statistics in the revised version of the manuscript. Through consultation with a statistician (Dr. Daniel Schnell, Cincinnati Children's Hospital Medical Center) we made the following adjustments in the revised version:

a\) In each of the figure legends we clearly indicated the statistical test performed.

b\) The reviewer is correct that it is not accurate to determine if a data set is normally distributed from 3 observations. To deal with this issue we increased the majority of observations to 4, and did not perform a normality test on data sets with less than 4 observations. After this analysis of normality there is only one data set that required a non-parametric test (we used a Mann Whitney sum rank test for Figure 1G).

c\) In the revised manuscript we used a 1-way ANOVA for data sets with one variable and a 2-way ANOVA for data sets with two variables. A multiple comparison test was used for each type of ANOVA.

> Results
>
> The authors discuss muscle damage a lot, but the molecular data they provide (Figure 3---figure supplement 2) is not really on molecules related to damage or repair/regeneration but rather to mechanical stress which might not always damage. If the authors still have extracts of muscles, they should be able to measure more relevant molecules such as heat-shock proteins or embryonal myosin (the latter can also be analysed on cryosections). It would also be useful if they could compare such markers between control and experimental groups, e.g. is the level higher in the mice that were tamoxifen injected at the onset than for other groups (controls and late injected.

We analyzed creatine kinase in the serum as a proxy for muscle damage. We did this in WT and Myomaker^scKO\ 8w^ mice at multiple time points after HIIT, and included the Results in the revised manuscript. We also now compare levels of mechanical stress genes between WT and Myomaker^scKO\ 8w^ mice. These data together show that HIIT-induced damage is increased in muscle that is fusion-incompetent (Myomaker^scKO\ 8w^ mice).

We did not observe evidence for embryonal myosin+ myofibers on cryosections. As another proxy for muscle damage/repair, we analyzed central nuclei in the myofibers after HIIT. Similar to the Myh3 analysis, the levels of central nuclei are low in the quadriceps (3-5% after 2 weeks of HIIT). The difficulty for detection of central nuclei or Myh3 in sections could be because they may occur in discrete regions of the muscle, and therefore missed by analyzing a section at the mid-belly of the muscle. In this instance, creatine kinase is likely a better readout for muscle damage because the levels are contributed from all muscles. Another reason to explain the low or absent levels of Myh3 and central nuclei is that there is some debate if those characteristics are associated with all types of muscle damage. This controversy was mentioned by reviewer \#2. Since this issue is still being debated in the field, we prefer not to show the Myh3 or central nuclei data because we think the analysis needs to be deeper before making a concrete statement.

> Discussion
>
> As mentioned, I find large parts of the Discussion problematic, for example:
>
> \"Exercise-induced adaptations involve the response to myofiber damage, increased contractile output, and growth of the myofiber, but it has been difficult to ascertain if myonuclear accrual is required for early exercise-related injury alone, adaptive growth alone, or both.\"
>
> I have never seen anybody suggest that myonuclear accrual should not be related to repair of injury. Very unclear statement, rephrase.

We rephrased this statement.

> \"Surprisingly, the HIIT protocol described here uncoupled these adaptive processes.\"
>
> I am not sure the data really show this. You would need to explain better or delete.

We provide a better explanation of this idea in the Discussion.

> \"We observed an increase in myonuclear numbers at each stage of HIIT indicating that MP fusion occurs and that accrual is not a consequence of a single event.\"
>
> I am not sure I understand this. What single event? Do you mean onset of exercise? I would interpret the data to mean that there is a gradual increase in the number of nuclei with a somewhat lagging increase in CSA during exercise. Bruusgaard et al., 2010 showed by overload that the MP fusion seemed to precede the CSA growth, and thus hinting on a causal relationship. When the authors here state \"It is interesting to consider that in WT mice myonuclear accretion occurs throughout HIIT but hypertrophy transpires at later stages.\" It sounds like a similar conclusion. Could the authors plot the data in a better way illustrating this point?

We agree that our data are consistent with Bruusgaard et al., 2010, and included this in the Discussion. One key advance in our study is that we not only show that increases in myonuclear numbers precedes hypertrophy, but also demonstrate that significant adaptive hypertrophy requires continued MP fusion and myonuclear accrual.

> \"This suggests that an increase in myonuclei does not necessarily indicate that hypertrophy is forthcoming, which could explain the inconsistencies of studies reporting a correlation between myonuclear number and myofiber size and other studies finding no correlation (Murach et al., 2018; Damas et al., 2018).\"
>
> I don\'t understand this argument. I have not seen anybody suggest that an increase in myonuclei is in itself is sufficient to induce hypertrophy. As I understand it the general idea has been that more myonuclei might be required for hypertrophy, but that some hypertrophic signal (for example load) is also required. For example, inactive nuclei-rich fibres will also atrophy if denervated. I also don\'t understand how the findings of Murach et al., 2018 (is a review not a study) and Damas et al., 2018, could be explained in this way?

We removed this statement in the overhauled Discussion.

> \"Since our data indicate that evidence of myonuclear accretion cannot be used simply to predict myofiber size, we propose that addition of myonuclei may serve specialized roles depending on the stage of adaptation. For instance, myonuclei could be recruited to the myofiber during exercise initiation to allow adaptation to moderate damage whereas myonuclear accretion at the later stages of HIIT could facilitate adaptive hypertrophy. Collectively, these observations agree with reports in humans that resistance training-induced hypertrophy occurs after suppression of damage (Damas et al., 2016)\".
>
> My interpretation would be that muscle fibres without new nuclei don\'t increase sufficiently in size and/or strength to cope with the forced HIIT and some of the fibres are ruptured. Muscle damage in untrained people that start to exercise abruptly and hard is well known (rhabdomyolysis), and here electroshock is used. I don\'t think this translates to specialized roles for nuclei depending on stage of adaption or that early accretion is necessarily related to damage. Has damage been observed in the control mice here? The title of Damas et al., 2016, rephrased here is misleading. As I understand it, the authors of that paper did not really suppress damage, they just compared synthesis during early phases with lots of repair and later phases with less repair and more radial growth. If this part is to be kept in the Discussion the relevance to the present paper needs to be explained better.

We now show damage in control HIIT-trained mice and have better explained our idea about myonuclear specialization while also discussing other possibilities. Specifically to the issue of damage, the creatine kinase data shows that injury begins early in HIIT and definitely precedes any increase in size, therefore we do not think that injury is solely a consequence of an inability to increase in size. It is possible the early increases in myonuclei lead to an increase in strength that help the muscle deal with HIIT, but strength was not measured early in the protocol, and we acknowledge that is a limitation.

> Reviewer \#2:
>
> \[...\] 1) I have only one substantive comment about the paper. The authors argue that the satellite cell contribution to myofibers during the first 4 weeks of HIIT serves a fundamentally different function than satellite cell contribution to myofibers during 4-8 weeks of HIIT. However, during the first 4 weeks of HIIT the mice were subjected to an increasing incline, while during the last 4 weeks the mice were subjected to increasing speed. Isn\'t the most parsimonious explanation of the difference in the function of satellite cell contribution during the first versus the second four weeks simply that these are different responses to increasing incline versus increasing speed? Would they see a difference if they simply increased monotonically either the incline or the speed throughout the 8 week HIIT? I do not propose that they re-do these experiments, but I think how to interpret the effects of inhibiting satellite cell fusion throughout the 8 weeks versus just the last 4 weeks of HIIT is unclear. At a minimum, the authors need to explicitly discuss this.

We agree that this alternative interpretation should be considered and included it in the Discussion.
